However, in a recently released study in the Journal of the COPD Foundation, researchers from Baylor College of Medicine and other institutions found that healthcare providers and patients prioritize medication over device when selecting treatments, showing limited concerns about proper device use.
“For COPD, there are several inhaler devices through which most medications are administered, but we noticed over the years that many patients don’t use their inhaler correctly,” said lead author Dr. Nicola Hanania, associate professor of medicine in the section of pulmonary, critical care and sleep medicine and director of the airways clinical research center at Baylor. “This study, which was conducted via a survey, aimed to look at both the healthcare providers and the patients’ perspectives and beliefs about inhaler devices used to treat their COPD.”
The study included two surveys, one targeting healthcare practitioners who treat COPD and the other targeting patients with COPD in the United States. A total of 513 survey responses were collected from healthcare practitioners, and 499 survey responses were collected from patients.
The study uncovered several gaps in healthcare practitioners’ and patients’ understanding of the role of inhalation devices in COPD management. After reviewing the surveys from each group, researchers found that patients and healthcare providers put how to use their inhaler device second in importance to the drug being used to treat their COPD.
Researchers also identified that there is a need for better education related to inhaler devices. Many patients are not getting an adequate amount of education from their healthcare practitioner about how to use their inhaler device. The study highlights potential unmet needs and opportunities for future interventions to coordinate professional and patient-directed education to further promote proper device selection and use in COPD management.
“Our results indicate that we need to reach out to healthcare providers and patients to educate them more about delivery systems that are available for COPD so that when it comes to getting the right medicine for the patient, the device choice should be part of the decision-making. It should be a shared decision between the patient and the clinician because many patients may not master one delivery system so their choice for choosing another one should be there,” Hanania said.
Other contributors to this work include Dr. Sidney Braman, Dr. Sandra G. Adams, Dr. Ruth Adewuya, Dr. Arzu Ari, Dr. JoAnn Brooks, Dr. Donald A. Mahler, Dr. Jill A. Ohar, Dr. Jay Peters, and Dr. Shahin Sanjar. The researchers are affiliated with one or more of the following institutions: Baylor College of Medicine, Icahn School of Medicine at Mount Sinai, University of Texas Health Science Center, South Texas Veterans Health Care System, American College of Chest Physicians, Texas State University, Indiana University Health, Geisel School of Medicine at Dartmouth, Wake Forest Health University Medical Center, and/or Sunovion Pharmaceuticals Inc.
This study was sponsored by the American College of Chest Physicians and supported by a grant from Sunovion Pharmaceuticals Inc., which provided funding for the implementation of the survey and medical writing but did not influence the design, conduct of the study or content of the submitted manuscript.